Target Gene Sequencing To Define the Susceptibility of Neisseria meningitidis to Ciprofloxacin

Abstract

ABSTRACTMeningococcalgyrAgene sequence data, MICs, and mouse infection were used to define the ciprofloxacin breakpoint forNeisseria meningitidis. Residue T91 or D95 of GyrA was altered in all meningococcal isolates with MICs of ≥0.064 μg/ml but not among isolates with MICs of ≤0.032 μg/ml. Experimental infection of ciprofloxacin-treated mice showed slower bacterial clearance when GyrA was altered. These data suggest a MIC of ≥0.064 μg/ml as the ciprofloxacin breakpoint for meningococci and argue for the molecular detection of ciprofloxacin resistance.